170 related articles for article (PubMed ID: 3910312)
1. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.
Krettli AU; Pontes de Carvalho LC
Clin Exp Immunol; 1985 Nov; 62(2):270-7. PubMed ID: 3910312
[TBL] [Abstract][Full Text] [Related]
2. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
Sher A; Hieny S; Joiner K
J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
[TBL] [Abstract][Full Text] [Related]
3. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
4. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
Melamed J; Medicus RG; Arnaout MA; Colten HR
J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
[TBL] [Abstract][Full Text] [Related]
5. gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.
Fischer E; Ouaissi MA; Velge P; Cornette J; Kazatchkine MD
Immunology; 1988 Oct; 65(2):299-303. PubMed ID: 2973433
[TBL] [Abstract][Full Text] [Related]
6. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement.
Tomlinson S; Pontes de Carvalho LC; Vandekerckhove F; Nussenzweig V
J Immunol; 1994 Oct; 153(7):3141-7. PubMed ID: 8089492
[TBL] [Abstract][Full Text] [Related]
7. Binding of complement to trypomastigotes of a Brazil strain of Trypanosoma cruzi: evidence for heterogeneity within the strain.
Jacobson KC; Washburn RG; Kuhn RE
J Parasitol; 1992 Aug; 78(4):697-704. PubMed ID: 1635029
[TBL] [Abstract][Full Text] [Related]
8. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.
Krettli AU; Weisz-Carrington P; Nussenzweig RS
Clin Exp Immunol; 1979 Sep; 37(3):416-23. PubMed ID: 116784
[TBL] [Abstract][Full Text] [Related]
9. Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
Tamerius JD; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1985 Sep; 135(3):2015-9. PubMed ID: 2410510
[TBL] [Abstract][Full Text] [Related]
10. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
[TBL] [Abstract][Full Text] [Related]
11. In-vitro lysis of sensitized Trypanosoma cruzi by platelets: role of C3b receptors.
Umekita LF; Mota I
Parasite Immunol; 1989 Sep; 11(5):561-6. PubMed ID: 2531362
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.
Norris KA; Bradt B; Cooper NR; So M
J Immunol; 1991 Oct; 147(7):2240-7. PubMed ID: 1717552
[TBL] [Abstract][Full Text] [Related]
13. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
Norris KA
Microb Pathog; 1996 Oct; 21(4):235-48. PubMed ID: 8905613
[TBL] [Abstract][Full Text] [Related]
14. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
Lambris JD; Ross GD
J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
[TBL] [Abstract][Full Text] [Related]
15. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
Arend WP; Massoni RJ
Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
Garred P; Mollnes TE; Lea T; Fischer E
Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
[TBL] [Abstract][Full Text] [Related]
17. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
Okuda T; Tachibana T
Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
[TBL] [Abstract][Full Text] [Related]
18. Three rat monoclonal antibodies to human C3.
Lachmann PJ; Oldroyd RG; Milstein C; Wright BW
Immunology; 1980 Nov; 41(3):503-15. PubMed ID: 6161872
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
20. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
Joiner K; Sher A; Gaither T; Hammer C
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
